Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
about
A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulenceRifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis.In vitro activity and fecal concentration of rifaximin after oral administrationDrug prophylaxis for travelers' diarrhea.Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis.Rifaximin versus ciprofloxacin for the treatment of traveler's diarrhea: a randomized, double-blind clinical trial.Effects of rifaximin administration on the intestinal microbiota in patients with ulcerative colitis.Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential.Rifaximin, a peculiar rifamycin derivative: established and potential clinical use outside the gastrointestinal tract.Rifaximin pharmacology and clinical implications.Antibiotics for irritable bowel syndrome: rationale and current evidence.Prevention and self-treatment of traveler's diarrhea.Rifaximin for the treatment of acute infectious diarrheaImpact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascitesDoes topical rifampicin reduce the risk of surgical field infection in hernia repair?Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.Rifaximin Is Effective for the Treatment of Clostridium difficile-Associated Diarrhea: Results of an Open-Label Pilot Study.Determination of rifaximin treatment period according to lactulose breath test values in nonconstipated irritable bowel syndrome subjects.Antibiotics for the treatment of irritable bowel syndromeReview article: the antimicrobial effects of rifaximin on the gut microbiota.Rifaximin, but not growth factor 1, reduces brain edema in cirrhotic rats.Rifaximin: a new treatment for travelers' diarrhea.Rifaximin: a nonabsorbable rifamycin antibiotic for use in nonsystemic gastrointestinal infections.Efficacy of rifaximin vaginal tablets in treatment of bacterial vaginosis: a molecular characterization of the vaginal microbiota.Experimental and clinical pharmacology of rifaximin, a gastrointestinal selective antibiotic.Current and future developments in travelers' diarrhea therapy.Rifaximin: a nonsystemic rifamycin antibiotic for gastrointestinal infections.Efficacy of rifaximin in prevention of travelers' diarrhea: a meta-analysis of randomized, double-blind, placebo-controlled trials.Rifamycins, Alone and in Combination.Rifampin and rifaximin resistance in clinical isolates of Clostridium difficile.In vitro activity of rifaximin against enteropathogens producing traveler's diarrheaRifaximin-ciprofloxacin combination therapy is effective in chronic active refractory pouchitis.Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome.Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth.Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations.The effect of sub-inhibitory concentrations of rifaximin on urease production and on other virulence factors expressed by Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa and Staphylococcus aureus.The effect of rifaximin on gut flora and Staphylococcus resistance.Novel Antimicrobials for the Treatment of Clostridium difficile Infection.Vaginal Mucosa and Drug Delivery
P2860
Q28295210-404C4A77-07C5-4000-8C7A-39F69A13CA5EQ33798014-07FA59B0-F5DB-49EA-B719-841A05773E22Q33980321-2FC75083-D083-42A8-AFE5-DA2163092B4EQ34110485-99410C0F-7DB4-4E09-B07A-13E3312FCBB9Q34504027-0855AF4A-93B1-4CDA-899C-0315FDFE22BCQ34519193-A1256AE3-72FA-4434-8717-BFBAA3E083DEQ34525343-81211A0A-8308-4698-835D-1C4A4E6A7134Q34557101-A6EC8C18-66DD-4AE1-8019-9A189026D2DCQ34557108-EDC623A6-3AC8-49B4-A65D-E71F2C890BA0Q34607677-5ADD077B-AEEF-453A-BF01-2EE639DE3C46Q34642080-6D29828B-4B2A-44D3-920E-93D17A281DE5Q34974972-8C446C74-E618-44DE-B9E7-4B3D0E63CCD3Q35090413-67AB14F4-3DAC-468B-A980-1CA389675125Q35143004-D6A1AE41-5E3C-459B-B359-589A579BB423Q35233490-F8F29D81-A671-4E61-8C12-0631D5B2187AQ35385384-24C0BAFF-D224-430E-9AE8-1B55221C215CQ35550741-DD48798B-04B0-4091-A54B-F8BC30078120Q35649153-3B884FB4-2F0F-4265-B967-81C8AF218DD6Q35691133-337DD317-3C93-4418-A366-083C848A8E4AQ35855732-13F9A948-03E3-4497-8B89-2626AB88E794Q35929182-E306C6DD-8A2D-4A0F-AFCF-C3B7E82F833FQ35983943-627FCFBD-7500-4213-A417-F12439BD9308Q36140657-D53E64C1-9C37-4D2F-A02B-048B0A6D27B3Q36171542-78BE64BF-D879-42DA-AB4B-0B8FBA11A505Q36404922-78E03CD6-718E-465A-A428-4B2684CCAFEAQ36505498-2B0CD8F6-19F2-4E91-80FC-003383A22741Q37768415-DC20C8B4-2E67-4EC4-A475-EAD244D13590Q38078988-00F46685-D628-4E51-B3E8-3F6C677B1EE4Q38857578-FBC36F1E-64E4-481D-A3D1-83DA15631CB6Q41336833-B05D4148-D2BF-4EA0-B64D-360D83FA78C9Q42730284-2610368F-5395-46ED-9BF9-88529A782BC6Q45273376-CDCA205B-5921-46E6-81D2-3F7E4D12BC7BQ46424972-EDE79958-E14E-4227-9547-3C8A7965816AQ46552846-FEA18682-6BD4-4293-BB99-BE73C14B46F5Q46604531-F6D6D169-6141-4153-AE57-E90DE3C63B21Q53781806-05FC3B62-F5EA-44FB-B847-F0D2B0B2858EQ54263702-04EFCA6F-E4C0-438D-AAD3-C9528C4B46FAQ55405974-2986DD52-40E6-4456-A0D3-384F7931ACBDQ57570821-D5247F58-F80C-4380-A02B-3E4A079130BA
P2860
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
description
1993 nî lūn-bûn
@nan
1993 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@ast
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@en
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@nl
type
label
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@ast
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@en
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@nl
prefLabel
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@ast
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@en
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@nl
P2093
P1476
Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative.
@en
P2093
E H Gerlach
G M Eliopoulos
M A Pfaller
W W Hoover
P304
P356
10.1016/0732-8893(93)90004-Q
P577
1993-02-01T00:00:00Z